SN
Subbu Nambi Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
44
Avg Return
Past Year
Past Year
5.9%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Industrials
Healthcare
Biotechnology
Diagnostics & Research
Health Information Services
Medical Devices
Medical Instruments & Supplies
Industrials
Integrated Freight & Logistics
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $120 |
51%
upside
| 1 | -12% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $4 |
32%
upside
| 1 | +2.1% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $440 |
34%
upside
| 1 | -11% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $50 |
16%
downside
| 1 | +12% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $7 |
33%
upside
| 1 | -9.3% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $13 |
93%
upside
| 1 | -7.4% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $170 |
26%
upside
| 2 | +20% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $130 |
151%
upside
| 1 | -15% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $135 |
49%
upside
| 2 | +22% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $47 |
88%
upside
| 2 | -14% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $58 |
43%
upside
| 2 | -15% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $21 |
45%
upside
| 1 | +5% |
0
%
| 26 Jan ‘26 2 months ago |
|